The effect of angiotensin II and other vasoactive drugs on isolated portal vein preparations.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001464:Barium / Q000494:pharmacology; D001681:Biological Assay; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D011169:Portal Vein / Q000187:drug effects*; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000804:Angiotensin II; D001464:Barium; D012701:Serotonin; D009538:Nicotine; D006632:Histamine; D004809:Ephedrine; D000109:Acetylcholine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine